These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47 related articles for article (PubMed ID: 1154325)
21. Antiplatelet drugs or dicoumarol: what is the most effective prophylaxis in occlusive arterial disease? Poliwoda H; Avenarius HJ Int Angiol; 1986; 5(3):169-80. PubMed ID: 2435823 [TBL] [Abstract][Full Text] [Related]
22. Failure of sulphinpyrazone to affect platelet survival in patients with rheumatic heart valvular disease: a double blind study using 75Se-methionine labeled platelets. Fabris F; Casonato A; Randi ML; Schivazappa L; Schiavinato L; Girolami A Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(4):594-601. PubMed ID: 6196274 [TBL] [Abstract][Full Text] [Related]
23. Platelet-active drugs in the secondary prevention of cardiovascular events: an overview. Weiss HJ Circulation; 1980 Dec; 62(6 Pt 2):V41-3. PubMed ID: 7002351 [TBL] [Abstract][Full Text] [Related]
24. Effect of acetylsalicylic acid, other nonsteroidal anti-inflammatory agents, and dipyridamole on human blood platelets. Zucker MB; Peterson J J Lab Clin Med; 1970 Jul; 76(1):66-75. PubMed ID: 5425364 [No Abstract] [Full Text] [Related]
25. The effect of sulphinpyrazone and other drugs on the platelet response during the acute phase of the active Arthus reaction in guinea pigs. Butler KD; Pay GF; Roberts JM; White AM Thromb Res; 1979; 15(3-4):319-40. PubMed ID: 158844 [No Abstract] [Full Text] [Related]
26. [The blood platelets in thrombogenesis. The mechanism and inhibition of the aggregation of blood platelets]. Born GV Actual Pharmacol (Paris); 1965; 18():17-32. PubMed ID: 5874959 [No Abstract] [Full Text] [Related]
28. Drugs in the treatment of thrombo-embolic disease--part I. Bouchier-Hayes D Ir Med J; 1983 Feb; 76(2):101-5, 107. PubMed ID: 6601642 [No Abstract] [Full Text] [Related]
29. Clinical trials of antiplatelet drug therapy in acute myocardial infarction, unstable angina, and aortocoronary bypass surgery. Cairns JA Cardiovasc Clin; 1987; 18(1):231-46. PubMed ID: 3300983 [No Abstract] [Full Text] [Related]
30. Platelet reactions and immune processes. II. The inhibition of platelet aggregation by complement inhibitors. Join F; Tremblay F Thromb Diath Haemorrh; 1969 Dec; 22(3):466-81. PubMed ID: 5382285 [No Abstract] [Full Text] [Related]
31. [Prostaglandins, blood platelets, and thrombosis]. Bousser MG Ann Med Interne (Paris); 1973 Apr; 124(4):351-4. PubMed ID: 4352683 [No Abstract] [Full Text] [Related]
32. [Pharmacology of anti-platelet agents]. Lecompte T; Kher A; Gaillard JL; Samama M J Mal Vasc; 1983; 8(1):3-16. PubMed ID: 6302191 [TBL] [Abstract][Full Text] [Related]
33. [Heparin and blood platelets]. Komarnicki M; Kaźmierczak M Pol Tyg Lek; 1989 Oct 2-16; 44(40-42):899-901. PubMed ID: 2487948 [No Abstract] [Full Text] [Related]
34. [Summary of the clinical papers on sulfinpyrazone (Anturan) under discussion with a preview of the current study program]. Fontanilles F Wien Med Wochenschr Suppl; 1980; 61():23-4. PubMed ID: 6930767 [No Abstract] [Full Text] [Related]